Population pharmacokinetic/pharmacogenetic modeling and design of a bayesian estimator for the therapeutic drug monitoring of tacrolimus in lung transplantation

被引：0
|
作者：
Monchaud, C. [1 ]
De Winter, B. [1 ]
Estenne, M. [1 ]
Reynaud-Gaubert, M. [1 ]
Pison, C. [1 ]
Stern, M. [1 ]
Kessler, R. [1 ]
Guillemain, R. [1 ]
Marquet, P. [1 ]
Rousseau, A. [1 ]
机构：
[1] Univ Limoges, INSERM, UMR S850, CHU Limoges, F-87065 Limoges, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
273
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [21] Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®
    Woillard, Jean-Baptiste
    de Winter, Brenda C. M.
    Kamar, Nassim
    Marquet, Pierre
    Rostaing, Lionel
    Rousseau, Annick
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (03) : 391 - 402
  • [22] Therapeutic drug monitoring of prednisolone after lung transplantation
    Morton, Judith M.
    Williamson, Sharon
    Kear, Laurie M.
    McWhinney, Brett C.
    Potter, Julia
    Glanville, Allan R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (05): : 557 - 563
  • [23] Pharmacokinetic modelling and development of Bayesian estimators for the therapeutic drug monitoring of Mycophenolate mofetil in non myeloablative haematopoietic cell transplantation
    Saini-Marcoux, F.
    Royer, B.
    Debord, J.
    Larosa, F.
    Legrand, F.
    Deconinck, E.
    Marquet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 22 - 22
  • [24] Voriconazole therapeutic drug monitoring-interindividual variability and pharmacokinetic modeling
    Markova, E.
    Kozakova, S.
    Horska, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1498 - 1498
  • [25] Therapeutic drug monitoring in lung transplant recipients receiving concomitant posaconazole and tacrolimus
    Quaranta, S.
    Reynaud-Gaubert, M.
    Solas, C.
    Bontface, S.
    Lacarelle, B.
    Sampol-Manos, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 26 - 27
  • [26] Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling
    Passot, Christophe
    Pouw, Mieke F.
    Mulleman, Denis
    Bejan-Angoulvant, Theodora
    Paintaud, Gilles
    Dreesen, Erwin
    Ternant, David
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 322 - 326
  • [27] Population Pharmacokinetic (PK) Modeling of Hydroxyurea for Therapeutic Drug Monitoring Applications in Children and Adolescents with Sickle Cell Disease
    Wiczling, Pawel
    Liem, Robert I.
    Panepinto, Julie A.
    Garg, Uttam
    Abdel-Rahman, Susan M.
    Kearns, Gregory L.
    Neville, Kathleen A.
    BLOOD, 2011, 118 (21) : 936 - 936
  • [28] Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome
    Saint-Marcoux, F.
    Guigonis, V.
    Decramer, S.
    Gandia, P.
    Ranchin, B.
    Parant, F.
    Bessenay, L.
    Libert, F.
    Harambat, J.
    Bouchet, S.
    Broux, F.
    Compagnon, P.
    Marquet, P.
    PHARMACOLOGICAL RESEARCH, 2011, 63 (05) : 423 - 431
  • [29] Validation of a Population Pharmacokinetic Model of Vortioxetine Using Therapeutic Drug Monitoring Data
    Trine Frederiksen
    Robert L. Smith
    Birgit M. Wollmann
    Johan Areberg
    Espen Molden
    Clinical Pharmacokinetics, 2021, 60 : 1475 - 1486
  • [30] Validation of a Population Pharmacokinetic Model of Vortioxetine Using Therapeutic Drug Monitoring Data
    Frederiksen, Trine
    Smith, Robert L.
    Wollmann, Birgit M.
    Areberg, Johan
    Molden, Espen
    CLINICAL PHARMACOKINETICS, 2021, 60 (11) : 1475 - 1486
12345